MARSHALL WACE, LLP - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 136 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$417,150
+72.9%
22,500
+3.1%
0.00%
Q2 2023$241,330
-84.1%
21,820
-80.7%
0.00%
-100.0%
Q1 2023$1,521,900
+249.1%
113,321
+322.3%
0.00%
+200.0%
Q1 2022$436,000
-34.8%
26,836
-34.6%
0.00%0.0%
Q4 2021$669,000
-59.1%
41,028
-62.7%
0.00%
-85.7%
Q3 2021$1,635,000
-7.7%
110,085
+43.5%
0.01%
-12.5%
Q1 2021$1,772,000
-2.3%
76,723
+4.5%
0.01%
-20.0%
Q4 2020$1,814,000
+13.2%
73,433
+90.1%
0.01%0.0%
Q3 2020$1,602,000
+5.3%
38,628
+186.9%
0.01%
-86.3%
Q1 2017$1,521,000
-86.3%
13,463
-86.8%
0.07%0.0%
Q4 2016$11,121,000
+85.3%
102,360
+180.7%
0.07%
+69.8%
Q3 2016$6,002,000
-61.5%
36,468
-66.6%
0.04%
-67.2%
Q2 2016$15,570,000
+3607.1%
109,127
+3241.3%
0.13%
+3175.0%
Q1 2016$420,000
-67.9%
3,266
-58.7%
0.00%
-75.0%
Q3 2015$1,310,000
+452.7%
7,900
+690.0%
0.02%
+433.3%
Q2 2014$237,0001,0000.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders